Baker Bros. Advisors Lp

13F Holdings History for Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (PRLD)

Symbol: PRLD on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 10.3M shares
Security Ownership: 23.5%

Shares, Excluding Options vs Price

Value, Excluding Options

Baker Bros. Advisors LP ownership in Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD)

2025-06-13 - Baker Bros. Advisors LP has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10.3M shares of Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD). This represents 23.5% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Baker Bros. Advisors LP	23.5%		$8.01M	10.3M			$0.78	13D/A	6/12/2025	13 Jun 2025 17:21:09

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.11%		$14.6M	10.1M			$1.44	Q3 2025
6/30/2025	0.08%		$8.19M	10.1M			$0.81	Q2 2025
3/31/2025	0.09%		$7.78M	10.1M			$0.77	Q1 2025
12/31/2024	0.14%		$12.9M	10.1M			$1.28	Q4 2024
9/30/2024	0.22%		$21M	10.1M			$2.07	Q3 2024
6/30/2024	0.49%		$38.6M	10.1M			$3.81	Q2 2024
3/31/2024	0.6%		$48M	10.1M			$4.74	Q1 2024
12/31/2023	0.49%		$43.2M	10.1M			$4.27	Q4 2023
9/30/2023	0.18%		$31.3M	10.1M			$3.09	Q3 2023
6/30/2023	0.26%		$45.6M	10.1M			$4.50	Q2 2023
3/31/2023	0.31%		$57.7M	10.1M			$5.70	Q1 2023
12/31/2022	0.37%		$61.1M	10.1M			$6.04	Q4 2022
9/30/2022	0.44%		$66.9M	10.1M			$6.61	Q3 2022
6/30/2022	0.3%		$52.8M	10.1M			$5.22	Q2 2022
3/31/2022	0.4%		$69.9M	10.1M			$6.90	Q1 2022
12/31/2021	0.61%		$126M	10.1M			$12.45	Q4 2021
9/30/2021	1.39%		$316M	10.1M			$31.25	Q3 2021
6/30/2021	1.27%		$290M	10.1M			$28.63	Q2 2021
3/31/2021	1.9%	+0%	$439M	10.1M	+5,188	+0.05%	$43.33	Q1 2021
12/31/2020	2.73%		$724M	10.1M			$71.55	Q4 2020
9/30/2020	1.22%	+1.22%	$305M	10.1M	+10,118,636	NEW	$30.13	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.